top of page

Publications in 2024

1056

In Situ Reprogramming of Immune Cells Using Synthetic Nanomaterials

Advanced materials (Deerfield Beach, Fla.), 2024, e2310168.

Nie, S., Qin, Y., Ou, L., Chen, X., & Li, L.

1055

First-in-human validation of enzymolysis clearance strategy for decreasing renal radioactivity using modified [68Ga]Ga-HER2 Affibody.

European journal of nuclear medicine and molecular imaging, 2024, 10.1007/s00259-023-06584-8.

Zhang, M., Kang, F., Xing, T., Wang, J., Ma, T., Li, G., Quan, Z., Yang, W., Chen, X., & Wang, J.

1054

Synergistic Glutathione Depletion and STING Activation to Potentiate Dendritic Cell Maturation and Cancer Vaccine Efficacy

Angewandte Chemie (International ed. in English), 2024, e202318530.

Liu, J., Zhang, Y., Yang, B., Jia, Y., Liu, R. T., Ding, L., Shen, Z., & Chen, X.

1053

Long-term Nephrotoxicity after PRRT: Myth or Reality.

Theranostics, 2024, 14(2), 451–459

Baum, R. P., Fan, X., Jakobsson, V., Yu, F., Schuchardt, C., Chen, X., & Zhang, J.

1052

Lower-grade gliomas surgery guided by GRPR-targeting PET/NIR dual-modality image probe: a prospective and single-arm clinical trial.

Theranostics, 2024, 14(2), 819–829

Chen, L., Zhang, J., Chi, C., Che, W., Dong, G., Wang, J., Du, Y., Wang, R., Zhu, Z., Tian, J., Ji, N., Chen, X., & Li, D.

1051

LCP1 knockdown in monocyte-derived macrophages: mitigating ischemic brain injury and shaping immune cell signaling and metabolism

Theranostics, 2024, 14(1), 159–175

Wang, Y., Yin, Q., Yang, D., Jin, H., Yao, Y., Song, J., Liu, C., Nie, Y., Yin, H., Wang, W., Xu, B., Xue, L., Ji, X., Chen, X., & Zhao, H.

bottom of page